NeuroSigma IPO Research Information

NeuroSigma IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on NeuroSigma, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
NeuroSigma	NSIG - NASDAQ	Postponed	$0.00	$0.00	3.6 million	10/9/2014
Underwriter(s): Jefferies
Co-Manager(s): BTIG, Craig-Hallum Capital Group
Industry:
Filing(s): Filed 2014-08-26 Terms Added 2014-09-29

About NeuroSigma (adapted from NeuroSigma prospectus):
They are a life sciences company focused on developing bioelectronic products with the potential to transform the lives of patients suffering from major neurological and neuropsychiatric disorders such as epilepsy and depression.

This description is adapted from Neurosigma prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Neurosigma "NSIG" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.